The DIRECTOR-GENERAL having regard to the European assessment Office determines 203 of February 25, 2015 concerning the marketing authorisation for the medicinal product KETOCONAZOLE HRA published in the official journal General series No 62 of March 16, 2015; Considering that, for clerical error concerning the name of the medicinal product by KETOCONAZOLE KETOCONAZOLE HRA HRA, the Office's determination that rectification should be European assessment; Having regard to official acts: Determines: (correction and amendment of resolution No. February 25, 2015 203 of the authorized medicinal product name KETOCONAZOLE HRA). Where is the name of the medicinal product: KETOCONAZOLE HRA read: KETOCONAZOLE HRA MAH: LABORATOIRE HRA PHARMA this determines will be published in the Official Gazette of the Italian Republic.
Roma, April 20, 2015 Director General: Pani